PMA device
TMX-2000 Thermatrx Office Thermo Therapy System
Boston Scientific Corp · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ, Class III) · First FDA decision Dec 15, 2006, newest Dec 15, 2006Enlarged prostate (BPH)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "TMX-2000 Thermatrx Office"
MAUDE reports
0
Brand "TMX-2000 Thermatrx Office", since 2015
PubMed studies
0
Mentioning "TMX-2000 Thermatrx Office"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TMX-2000 Thermatrx Office Thermo Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TMX-2000 THERMATRX OFFICE THERMO THERAPY SYSTEMPMA supplement
P000043-S015 · Decided Dec 15, 2006 · 149 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TMX-2000 Thermatrx Office", any status and sponsor, newest update first.
No registered device study names "TMX-2000 Thermatrx Office".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TMX-2000 Thermatrx Office", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MEQ
3 reports: 1 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TMX-2000 Thermatrx Office"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MEQ.
- Urologix Targis SystemUrologix, LLC · PMA 2015
- Prolieve Thermodilatation SystemMedifocus, Inc. · PMA 2007
- TMX-2000 BphBoston Scientific Corp · PMA 2004
- Prostalund Coretherm System and Prostaland Coretherm AccessoriesProstalund AB · PMA 2014
- Prolieve Thermodilitation SystemMedifocus, Inc. · PMA 2011
- Coretherm System Microwave ThermotherapyProstalund AB · PMA 2009
- ProstatronUrologix, Inc. · PMA 2005
- Prolieve Thermodilation SystemMedifocus, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.